| Followers | 7 |
| Posts | 690 |
| Boards Moderated | 0 |
| Alias Born | 06/01/2021 |
Wednesday, January 12, 2022 12:02:22 PM
Link to what? I'm translating the confirmed released PRs.
The burden of proof is on you making these claims. And you simply do not have the smoking gun, confirmed connection between SBFM-PL4 and the UGA polyphenol study. All you can find is circumstantial evidence.
There's no link I can send to prove that it will suck if Sunshine allowed share price to fall and no information to be released on SBFM-PL4 as they allowed UGA to publish a study about it but anonymously.
Also what is the connection between polyphenols and polyproteins? What claim are you making with that? You copy all these things that don't go together and say "can't help you if you don't understand." And then when I go one level of scrutiny deeper there is no concrete connection.
The burden of proof is on you making these claims. And you simply do not have the smoking gun, confirmed connection between SBFM-PL4 and the UGA polyphenol study. All you can find is circumstantial evidence.
There's no link I can send to prove that it will suck if Sunshine allowed share price to fall and no information to be released on SBFM-PL4 as they allowed UGA to publish a study about it but anonymously.
Also what is the connection between polyphenols and polyproteins? What claim are you making with that? You copy all these things that don't go together and say "can't help you if you don't understand." And then when I go one level of scrutiny deeper there is no concrete connection.
Recent SBFM News
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
